FemPro (Letrozole) 2.5mg
₨ 4,455
FemPro 2.5mg (Letrozole) tablets are used to treat hormone-receptor-positive breast cancer in postmenopausal women. It helps lower estrogen levels, slowing cancer cell growth and improving treatment outcomes.
Additional information
FemPro 2.5mg contains Letrozole, a medication used to treat breast cancer in postmenopausal women. It works by lowering the amount of estrogen in the body, which can slow the growth of certain types of breast cancer that depend on estrogen to grow. Letrozole is commonly prescribed after surgery or radiation therapy as part of the treatment plan for hormone-receptor-positive breast cancer.
Key Features:
-
Hormone Therapy for Breast Cancer: FemPro is used to treat hormone-receptor-positive breast cancer, helping to prevent cancer recurrence.
-
Lowers Estrogen Levels: Letrozole works by reducing estrogen, which is known to fuel the growth of certain types of breast cancer.
-
Postmenopausal Women: It is specifically used for postmenopausal women, who are at an increased risk for hormone-receptor-positive breast cancer.
-
2.5mg Dose for Effective Treatment: Each tablet contains 2.5mg of Letrozole, ensuring the correct dose for effective cancer treatment.
-
30 Tablets Per Pack: With 30 tablets in a pack, FemPro offers a one-month supply for continuous therapy.
Uses:
-
Treatment for hormone-receptor-positive breast cancer in postmenopausal women
-
Adjuvant treatment after surgery or radiation therapy
-
Helps reduce the risk of cancer recurrence